Engineer I, Plastics Integration at Illumina

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, Medical DevicesIndustries

Requirements

B.S. or M.S. in mechanical engineering, biomedical engineering, material science or related field with 0-3 years of experience in medical product design and development
Solid grasp of engineering fundamentals (mechanics of materials, materials, fluid mechanics, heat transfer, etc.)
Experience creating 3D models and 2D drawings in CAD (SolidWorks preferred)
Experience using GD&T and tolerance analysis preferred
Familiarity with machine shop tools and 3D printing for prototyping
Strong verbal/written communication and presentation skills
Thrives in a fast-paced, highly collaborative environment

Responsibilities

Design, analyze, test, and qualify consumable/disposable devices from early development into full scale manufacturing
Conduct tolerance analyses and produce component and assembly level specifications
Work with broader team to define specifications, critical parameters, test plans, etc
Develop test plans/protocols, conduct characterization studies, and draft reports to document design verification activities
Independently plan, manage, and prioritize tasks/projects, track progress toward project goals, and provides periodic updates to core team
Collaborate across sites with cross-disciplines like user experience, industrial design, manufacturing process, packaging, fluidics, chemistry, etc. to support development efforts
Work with suppliers for component/assembly prototyping and production

Skills

Plastics Design

Injection Molding

CAD Modeling

Materials Selection

Prototyping

Tolerance Analysis

Design Verification

Test Planning

Manufacturing Transfer

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free